Target intelligence / Profile preview

PRELI domain containing 3B pseudogene 1 (PRELID3BP1)

Target: PRELID3BP1
Molecular classification: Other (pseudogene)

Overview

PRELI domain containing 3B pseudogene 1 (PRELID3BP1) is classified as a pseudogene in the human genome with the approved symbol PRELID3BP1 and is not known to encode a functional protein. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they may arise from gene duplication or retrotransposition events and typically do not produce proteins, though some can have regulatory functions at the RNA level. PRELID3BP1's biological function, relevance to disease, and clinical significance, if any, are currently unknown, and there is no evidence indicating its utility as a drug target.

Beyond the preview

Go deeper on PRELI domain containing 3B pseudogene 1 (PRELID3BP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRELI domain containing 3B pseudogene 1 (PRELID3BP1).

Explore the full profile